324 related articles for article (PubMed ID: 32307830)
1. LncRNA HOTTIP facilitates the stemness of breast cancer via regulation of miR-148a-3p/WNT1 pathway.
Han L; Yan Y; Zhao L; Liu Y; Lv X; Zhang L; Zhao Y; Zhao H; He M; Wei M
J Cell Mol Med; 2020 Jun; 24(11):6242-6252. PubMed ID: 32307830
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-148a-3p suppresses epithelial-to-mesenchymal transition and stemness properties via Wnt1-mediated Wnt/β-catenin pathway in pancreatic cancer.
Fu X; Hong L; Yang Z; Tu Y; Xin W; Zha M; Tu S; Sun G; Li Y; Xiao W
J Cell Mol Med; 2020 Nov; 24(22):13020-13035. PubMed ID: 33026174
[TBL] [Abstract][Full Text] [Related]
3. LncCCAT1 Promotes Breast Cancer Stem Cell Function through Activating WNT/β-catenin Signaling.
Tang T; Guo C; Xia T; Zhang R; Zen K; Pan Y; Jin L
Theranostics; 2019; 9(24):7384-7402. PubMed ID: 31695775
[No Abstract] [Full Text] [Related]
4. Long non-coding RNA LUCAT1/miR-5582-3p/TCF7L2 axis regulates breast cancer stemness via Wnt/β-catenin pathway.
Zheng A; Song X; Zhang L; Zhao L; Mao X; Wei M; Jin F
J Exp Clin Cancer Res; 2019 Jul; 38(1):305. PubMed ID: 31300015
[TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA HOTTIP promotes the metastatic potential of ovarian cancer through the regulation of the miR-615-3p/SMARCE1 pathway.
Wu H; Wei HY; Chen QQ
Kaohsiung J Med Sci; 2020 Dec; 36(12):973-982. PubMed ID: 32783402
[TBL] [Abstract][Full Text] [Related]
6. microRNA-128-3p overexpression inhibits breast cancer stem cell characteristics through suppression of Wnt signalling pathway by down-regulating NEK2.
Chen Y; Wu N; Liu L; Dong H; Liu X
J Cell Mol Med; 2020 Jul; 24(13):7353-7369. PubMed ID: 32558224
[TBL] [Abstract][Full Text] [Related]
7. LncRNA SPRY4-IT1 regulates breast cancer cell stemness through competitively binding miR-6882-3p with TCF7L2.
Song X; Zhang X; Wang X; Chen L; Jiang L; Zheng A; Zhang M; Zhao L; Wei M
J Cell Mol Med; 2020 Jan; 24(1):772-784. PubMed ID: 31736268
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA HOTTIP promotes renal cell carcinoma progression through the regulation of the miR-615/IGF-2 pathway.
Wang Q; Wu G; Zhang Z; Tang Q; Zheng W; Chen X; Chen F; Li Q; Che X
Int J Oncol; 2018 Nov; 53(5):2278-2288. PubMed ID: 30226576
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of lncRNA HOTTIP Inhibits Retinoblastoma Progression by Modulating the miR-101-3p/STC1 Axis.
Yuan X; Sun Z; Cui C
Technol Cancer Res Treat; 2021; 20():1533033821997831. PubMed ID: 33784880
[TBL] [Abstract][Full Text] [Related]
10. Dysregulation of LncRNA ANRIL mediated by miR-411-3p inhibits the malignant proliferation and tumor stem cell like property of multiple myeloma via hypoxia-inducible factor 1α.
Wang M; Zhao HY; Zhang JL; Wan DM; Li YM; Jiang ZX
Exp Cell Res; 2020 Nov; 396(1):112280. PubMed ID: 32961145
[TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNA LINC00511 contributes to breast cancer tumourigenesis and stemness by inducing the miR-185-3p/E2F1/Nanog axis.
Lu G; Li Y; Ma Y; Lu J; Chen Y; Jiang Q; Qin Q; Zhao L; Huang Q; Luo Z; Huang S; Wei Z
J Exp Clin Cancer Res; 2018 Nov; 37(1):289. PubMed ID: 30482236
[TBL] [Abstract][Full Text] [Related]
12. LncRNA XIST knockdown suppresses the malignancy of human nasopharyngeal carcinoma through XIST/miRNA-148a-3p/ADAM17 pathway in vitro and in vivo.
Shi J; Tan S; Song L; Song L; Wang Y
Biomed Pharmacother; 2020 Jan; 121():109620. PubMed ID: 31810117
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA RP11-283G6.5 confines breast cancer development through modulating miR-188-3p/TMED3/Wnt/β-catenin signalling.
Pei J; Zhang S; Yang X; Han C; Pan Y; Li J; Wang Z; Sun C; Zhang J
RNA Biol; 2021 Oct; 18(sup1):287-302. PubMed ID: 34130584
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA HOTTIP is frequently up-regulated in hepatocellular carcinoma and is targeted by tumour suppressive miR-125b.
Tsang FH; Au SL; Wei L; Fan DN; Lee JM; Wong CC; Ng IO; Wong CM
Liver Int; 2015 May; 35(5):1597-606. PubMed ID: 25424744
[TBL] [Abstract][Full Text] [Related]
15. HOTTIP knockdown inhibits cell proliferation and migration via regulating miR-490-3p/HMGB1 axis and PI3K-AKT signaling pathway in ox-LDL-induced VSMCs.
Guo X; Liu Y; Zheng X; Han Y; Cheng J
Life Sci; 2020 May; 248():117445. PubMed ID: 32081664
[TBL] [Abstract][Full Text] [Related]
16. LncRNA HOTTIP modulates cancer stem cell properties in human pancreatic cancer by regulating HOXA9.
Fu Z; Chen C; Zhou Q; Wang Y; Zhao Y; Zhao X; Li W; Zheng S; Ye H; Wang L; He Z; Lin Q; Li Z; Chen R
Cancer Lett; 2017 Dec; 410():68-81. PubMed ID: 28947139
[TBL] [Abstract][Full Text] [Related]
17. LncRNA TUG1 contributes to ESCC progression via regulating miR-148a-3p/MCL-1/Wnt/β-catenin axis in vitro.
Tang Y; Yang P; Zhu Y; Su Y
Thorac Cancer; 2020 Jan; 11(1):82-94. PubMed ID: 31742924
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA MALAT1 mediates stem cell-like properties in human colorectal cancer cells by regulating miR-20b-5p/Oct4 axis.
Tang D; Yang Z; Long F; Luo L; Yang B; Zhu R; Sang X; Cao G; Wang K
J Cell Physiol; 2019 Nov; 234(11):20816-20828. PubMed ID: 31012108
[TBL] [Abstract][Full Text] [Related]
19. Regulation of laryngeal squamous cell cancer progression by the lncRNA H19/miR-148a-3p/DNMT1 axis.
Wu T; Qu L; He G; Tian L; Li L; Zhou H; Jin Q; Ren J; Wang Y; Wang J; Kan X; Liu M; Shen J; Guo M; Sun Y
Oncotarget; 2016 Mar; 7(10):11553-66. PubMed ID: 26872375
[TBL] [Abstract][Full Text] [Related]
20. LncRNA HOXA11-AS promotes migration and invasion through modulating miR-148a/WNT1/β-catenin pathway in gastric cancer.
Guo T; Yuan X; Liu DF; Peng SH; Xu AM
Neoplasma; 2020 May; 67(3):492-500. PubMed ID: 32009419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]